Objective breath and lung-function measurement for healthcare professionals.
At GattyInstruments AB (GIAB), our vision is to support more objective and accessible respiratory assessment in clinical care through reliable, data-driven tools. Our mission is to improve the quality and consistency of lung function evaluation to support healthcare professionals in making better routine clinical decisions. We aim to advance respiratory healthcare by enabling practical and scalable approaches.
Quality, Accountability, Responsibility,
and Transparency
Everything we develop at GattyInstruments is founded on our four pillars of strength, known as QART: Quality, Accountability, Responsibility, and Transparency. Through these core principles, we are developing medical device systems such as Spiroluft under an ISO 13485 quality management system that empower healthcare professionals with objective physiological measurement data to support confident, informed clinical decision-making.
Products
Spiroluft measures exhaled CO and lung function in one session and sends results via Bluetooth to the Spiroluft tablet application for review by the healthcare professional.
About COPD
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of illness and death worldwide and is characterised by persistent airflow limitation.¹ Tobacco smoking is its most important risk factor, and stopping smoking is the most effective way to slow the decline in lung function.¹ Structured smoking-cessation programmes therefore play a central role in respiratory health. Objective measurements, such as exhaled carbon monoxide to confirm recent smoking status, help healthcare professionals support patients through these programmes.²
Spiroluft is under development and is not CE-marked. It is intended for use by trained healthcare professionals in smoking-cessation care and is not intended for COPD screening or diagnosis.
¹ Global Initiative for Chronic Obstructive Lung Disease (GOLD), Global Strategy for the Prevention, Diagnosis and Management of COPD, 2026 Report.
² e.g. NICE guideline NG209, Tobacco: preventing uptake, promoting quitting and treating dependence.
Growth & Milestones
Received Vinnova Planning Grant for International Proposal 2025
Became a member of Svenska Medtechföreningen (SvMTF).
Became a member of International Association of Breath Research (IABR).
Received Vinnova Grant for feasibility studies.
Our Collaborators
